Thymidine kinase 2 deficiency research hub

A Phase 2 Open-Label Study of Continuation Treatment with Combination Pyrimidine Nucleosides in Patients with Thymidine Kinase 2 Deficiency (TK2)

This clinical study tests a combination treatment called doxecitine and doxribtimine for adults with thymidine kinase 2 deficiency (TK2d). Researchers want to see how safe the treatment is when taken over time, monitor side effects, and check if it helps improve patients' overall health and daily symptoms.